This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Sunesis Pharmaceuticals (small-molecule oncology therapeutics) has raised $45mm from a private placement. It sold 7.25mm common shares--that carry warrants to buy an additional 2.17mm common--for $6.21 each (a 7% premium to the market average). Investors, including Deerfield Management, Baker Brothers Investments, funds managed by Alta Partners, and existing backer Warburg Pincus, paid an additional $0.125 for each share underlying the warrants (equal to $271,250). Cowen & Co. acted as the placement agent.
Private Investment in Public Equity
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?